Robert Langreth Benjamin Elgin

For the past two years federal regulators have issued subpoenas and scrutinized relationships between drug companies and the charities, which are supposed to operate independently from industry donors.

Trending Stories

1
Enterprise ICHRA: A Playbook for Benefits Advisors
2
Mark Cuban praises Trump's PBM executive order, predicts 'hundreds of billions' in savings
3
Arkansas law bans PBM ownership of pharmacies
4
Whole Foods settles its 401(k) excessive fee lawsuit that cost workers millions
5
401(k) contribution limit projections for 2026: Milliman

For questions about BenefitsPRO, please call 800-458-1734 (9:00am-5:30pm ET, Monday through Friday, except holidays), or send an email to [email protected].

TopicsBenefits Broker Benefits Manager Retirement Advisor Expert Perspectives Special Reports Luminaries Advisor of the Year

ResourcesWebcasts Podcasts Resource Center Events Career Center Judy Diamond Sitemap

SupportAbout Us Advertise With Us Asset & Logo Licensing Contact Us

LegalCookie Policy Terms of Service Privacy Policy

Your Account Sign In Create Account Forgot Password My Newsletters

Business & Finance Network of Sites

ThinkAdvisor PropertyCasualty360 BenefitsPRO Credit Union Times GlobeSt Treasury & Risk Consulting Mag Bookstore